UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel

BMC cancer, 2022-12, Vol.22 (1), p.1343-1343, Article 1343

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel

Breast (Edinburgh), 2022-12, Vol.66, p.236-244

2022

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

Cancers, 2022-11, Vol.14 (21), p.5399

2022

Link zum Volltext

Verfügbarkeit prüfen

App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trial

Frontiers in oncology, 2024, Vol.14, p.1354377-1354377

2024

Link zum Volltext

Verfügbarkeit prüfen

Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer

Breast cancer research and treatment, 2019-08, Vol.176 (3), p.495-506

2019

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars in oncology: Effects on economy and therapeutic innovations

European journal of cancer (1990), 2020-11, Vol.139, p.10-19

2020

Link zum Volltext

Verfügbarkeit prüfen

Overall cancer survival inequalities in the state of São Paulo: A comparison between public and private systems

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6525-6525

2022

Link zum Volltext

Verfügbarkeit prüfen

Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients

Cancer, 2008-11, Vol.113 (9), p.2431-2439

2008

Link zum Volltext

Verfügbarkeit prüfen

Werden Männer und Frauen mit Brustkrebs in Deutschland gleichbehandelt?

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2020-09, Vol.155, p.1-10

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS10-32: Patient reported outcomes (PROs) with poly(ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy (CTX) in patients (pts) with germline BRCA1/2 mutated ( gBRCA1/2 mut) HER2- advanced breast cancer (ABC): Results from a multi-country real-world (RW) study

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-32-PS10-32

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS10-47: Physician and patient satisfaction with poly(ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy in adult patients with germline BRCA1/2 mutated (gBRCA1/2mut) HER2- advanced breast cancer (ABC): Results from a multi-country real-world (RW) study

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-47-PS10-47

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries

Breast care (Basel, Switzerland), 2022-10, Vol.17 (5), p.460-469

2022

Link zum Volltext

Verfügbarkeit prüfen

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast Cancer

Geburtshilfe und Frauenheilkunde, 2023-03, Vol.83 (3), p.321-332

2023

Link zum Volltext

Verfügbarkeit prüfen

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?

Geburtshilfe und Frauenheilkunde, 2023-03, Vol.83 (3), p.321-332

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of prognostic gene expression profiling tests in primary breast cancer treatment: a German real-world patient survey

Future oncology (London, England), 2022-12, Vol.18 (39), p.4371-4383

2022

Link zum Volltext

Verfügbarkeit prüfen

IBRCA1/2/I Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

Cancers, 2022-11, Vol.14 (21)

2022

Link zum Volltext

Verfügbarkeit prüfen

Short-Term Effects of Treatment-Induced Hormonal Changes on Cognitive Function in Breast Cancer Patients : Results of a Multicenter, Prospective, Longitudinal Study

Cancer, 2008-11, Vol.113 (9), p.2431-2439

2008

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022

Geburtshilfe und Frauenheilkunde, 2022-10, Vol.82 (10), p.1031-1043

2022

Link zum Volltext

Verfügbarkeit prüfen

PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABC

Future oncology (London, England), 2022-11, Vol.18 (36), p.3971-3982

2022

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Geburtshilfe und Frauenheilkunde, 2021-10, Vol.81 (10), p.1112-1120

2021

Link zum Volltext

Verfügbarkeit prüfen

Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study

Psycho-oncology (Chichester, England), 2010-12, Vol.19 (12), p.1321-1328

2010

Link zum Volltext

Verfügbarkeit prüfen

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

Cancer management and research, 2021-01, Vol.13, p.8457-8471

2021

Link zum Volltext

Verfügbarkeit prüfen

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019

Breast care (Basel, Switzerland), 2019-08, Vol.14 (4), p.224-245

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Oncology
(22)
Humans
(18)
Female
(17)
Breast Cancer
(13)
Obstetrics & Gynecology
(10)
Adult
(9)
Middle Aged
(9)
Breast Neoplasms - Drug Therapy
(8)
Aged
(7)
Clinical Trials
(7)
Cancer
(6)
Medicine
(6)
Medicine & Public Health
(6)
Patients
(6)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Breast Neoplasms - Genetics
(5)
Quality Of Life
(5)
Gebfra Science
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel

Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel

BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trial

Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer

Biosimilars in oncology: Effects on economy and therapeutic innovations

Overall cancer survival inequalities in the state of São Paulo: A comparison between public and private systems

Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients

Werden Männer und Frauen mit Brustkrebs in Deutschland gleichbehandelt?

Abstract PS10-32: Patient reported outcomes (PROs) with poly(ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy (CTX) in patients (pts) with germline BRCA1/2 mutated ( gBRCA1/2 mut) HER2- advanced breast cancer (ABC): Results from a multi-country real-world (RW) study

Abstract PS10-47: Physician and patient satisfaction with poly(ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy in adult patients with germline BRCA1/2 mutated (gBRCA1/2mut) HER2- advanced breast cancer (ABC): Results from a multi-country real-world (RW) study

Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast Cancer

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?

Use of prognostic gene expression profiling tests in primary breast cancer treatment: a German real-world patient survey

IBRCA1/2/I Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

Short-Term Effects of Treatment-Induced Hormonal Changes on Cognitive Function in Breast Cancer Patients : Results of a Multicenter, Prospective, Longitudinal Study

AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022

Association between pCR, TILs, and Ki-67 at baseline and after 2 weeks in patients with triple-negative breast cancer (TNBC) treated with atezolizumab and chemotherapy +/- a preceding atezolizumab monotherapy window: A translational analysis of the neoMono trial

MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET)

PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABC

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019

Suchergebnisse filtern